A KAIST research team reported a foundational technology for DNA synthesis using only temperature instead of chemical reagents, challenging a long-held assumption in biotechnology manufacturing. The team described a DNA temperature “black box” that records temperature changes during shipping without electricity. The work reframes DNA synthesis logistics by decoupling aspects of the process from chemical reagent handling, which could reduce operational complexity for downstream providers and potentially enable new supply-chain models for DNA fabrication. For drug discovery and enabling technologies, temperature-controlled DNA synthesis—if validated at scale—could affect how teams prototype constructs, distribute materials, and maintain consistency across production runs.